Pregnancy and perinatal outcomes of COVID-19 (SARS-CoV-2)

Literature review




coronavirus infection, COVID-19, SARS-CoV-2, pregnancy, perinatal consequences, newborns


This article presents current data on the impact of COVID-19 (SARS-CoV-2) on pregnancy and perinatal consequences. The working theories of the pathogenesis of obstetric and fetal complications due to infection during pregnancy, already proven to date, are considered.
Symptoms of COVID-19 disease, the risk of their development, and frequency of severe disease in non-pregnant and pregnant women of reproductive age do not differ significantly. However, there are powerful studies that have shown that this infection in pregnant women leads to a high probability of a dramatically severe and fulminant course. Pregnant women with SARS-CoV-2 infection have an increased risk of preeclampsia, incl. severe, hemolysis, thrombocytopenia and increased levels of liver enzymes compared with pregnant women without infection. Women who have COVID-19 are twice as likely to have preterm rupture of the membranes and three times as likely to have a preterm birth compared to the not infected pregnant women.
Vertical transmission of the virus from mother to fetus is likely, but data are insufficient to be certain. There is also insufficient evidence of an increased miscarriage rate and teratogenic effects of the COVID-19 virus. However, antenatal fetal death is statistically significantly more common in infected pregnant women than in uninfected pregnant women. Morphological and functional disorders in the chorion/placenta are the main pathogenetic factor in the development of preeclampsia, intrauterine growth retardation, antenatal fetal death and impaired state of the fetus and children born by women with COVID-19.
Many studies report that mothers with confirmed COVID-19 infection has asymptomatic babies. At the same time, some studies indicate adverse complications in newborns from infected mothers. The most common neonatal disorders in babies from pregnant women with COVID-19 are tachypnea, hyperthermia, and gastrointestinal disorders, in particular vomiting and flatulence.

Author Biographies

N.V. Herevych, SI “O.M. Lukyanova Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine”, Kyiv

PhD, senior researcher, Department of pathology of pregnancy and childbirth

I.A. Zhabchenko, SI “O.M. Lukyanova Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine”, Kyiv

MD, professor, сhief of the Department of pathology of pregnancy and childbirth

Y.A. Kravtsova, Luhansk State Medical University, Rubizhne

Assistant, Department of Obstetrics and Gynecology

O.R. Siudmak, SI “O.M. Lukyanova Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine”, Kyiv

Junior researcher, Department of pathology of pregnancy and childbirth

T.M. Kovalenko, SI “O.M. Lukyanova Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine”, Kyiv

PhD in physical education and sport, senior researcher, Department of pathology of pregnancy and childbirth

O.M. Bondarenko, SI “O.M. Lukyanova Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine”, Kyiv

PhD, senior researcher, Department of pathology of pregnancy and childbirth

I.S. Lishchenko, SI “O.M. Lukyanova Institute of Pediatrics, Obstetrics and Gynecology of the NAMS of Ukraine”, Kyiv

PhD, researcher, Department of pathology of pregnancy and childbirth


  1. Huang, C., Wang, Y., Li, X., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.” Lancet 395 (2020): 497–506.
  2. Liu, W., Wang, Q., Zhang, Q., et al. Coronavirus disease 2019 (COVID-19) during pregnancy: a case series (2020).
  3. Radzinsky, V.E., Knyazev, S.A., Kostin, I.N. Predictive obstetrics. Moscow. Status Presence Media Bureau (2021): 520 p.
  4. Aylward, B., Liang, W., Dong, X., et al. Report of the WHO China joint mission on coronavirus disease 2019 (COVID-19). Beijing: World Health Organisation (2020).
  5. Chen, H., Guo, J., Wang, C., et al. “Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.” Lancet 395 (2020): 809–15.
  6. Zhu, H., Wang, L., Fang, C., et al. “Clinical analysis of 10 neonates born to mothers with 2019-nCov pneumonia.” Transl Pediatr 9 (2020): 51–60.
  7. Wang, X., Zhou, Z., Zhang, J., et al. “A case of 2019 novel coronavirus in a pregnant woman with preterm delivery.” Clin Infect Dis 71.15 (2020): 844–6.
  8. Liu, D., Li, L., Wu, X., et al. “Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis.” Am J Roentgenol 215 (2020): 1–6.
  9. Yu, N., Li, W., Kang, Q., et al. “Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study.” Lancet Infect Dis 20.5 (2020): 559–64.
  10. Li, Y., Zhao, R., Zheng, S., et al. “Lack of vertical transmission of severe acute respiratory syndrome coronavirus 2, China.” Emerg Infect Dis 26.6 (2020): 1335–6.
  11. Fan, C., Lei, D., Fang, C., et al. “Perinatal transmission of COVID-19 associated SARS-CoV-2: should we worry?” Clin Infect Dis 2.5 (2020): 862–4.
  12. Wang, S., Guo, L., Chen, L., et al. “A case report of neonatal 2019 coronavirus disease in China.” Clin Infect Dis 71.15 (2020): 853–7.
  13. Zambrano, L., Fuentes-Barahona, I., Bejarano-Torres, D., et al. “A pregnant woman with COVID-19 in Central America.” Travel Med Infect Dis 36 (2020): 101639.
  14. Iqbal, S., Overcash, R., Mokhtari, N., et al. “An uncomplicated delivery in a patient with COVID-19 in the United States.” N Engl J Med 382.16 (2020): e34.
  15. Lee, D., Lee, J., Kim, E., et al. “Emergency cesarean section on severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) confirmed patient.” Korean J Anesthesiol 73.4 (2020): 347–51.
  16. Liu, H., Liu, F., Li, J., et al. “Clinical and CT imaging features of the COVID-19 pneumonia: focus on pregnant women and children.” J Infect 80.5 (2020): e7–13.
  17. Akhtar, H., Patel, C., Abuelgasim, E., Harky, A. “COVID-19 (SARS-CoV-2) Infection in Pregnancy: A Systematic Review.” Gynecol Obstet Invest 85 (2020): 295–306.
  18. Allotey, J., Stallings, E., Bonet, M., et al. “Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis.” BMJ 370 (2020): m3320.
  19. Karami, P., Naghavi, M., Feyzi, A., et al. “Mortality of a pregnant patient diagnosed with COVID-19: a case report with clinical, radiological, and histopathological findings.” Travel Med Infect Dis (2020): 101665.
  20. Chen, S., Liao, E., Cao, D., et al. “Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia.” J Med Virol 92.9 (2020): 1556–61.
  21. COVID Surg Collaborative. “Mortality and pulmonary complications in patients undergoing surgery with perioperative SARSCoV-2 infection: an international cohort study.” Lancet 396.10243 (2020): 27–38.
  22. Hantoushzadeh, S., Shamshirsaz, A.A., Aleyasin, A., et al. “Maternal death due to COVID-19 disease.” Am J Obst Gynecol 223.1 (2020): 109.e1–e16.
  23. Khalil, A., Kalafat, E., Benlioglu, C., et al. “SARS-CoV-2 infection in pregnancy: A systematic review and metaanalysis of clinical features and pregnancy outcomes.” Clinical Medicine 25 (2020): 100446.
  24. Dong, L., Tian, J., He, S., et al. “Possible vertical transmission of SARS CoV-2 from an infected mother to her newborn.” JAMA 323.18 (2020): 1846–48.
  25. Penfield, C.A., Brubaker, S.G., Limaye, M.A., et al. “Detection of SARS-COV-2 in placental and fetal membrane samples.” Am J Obstet Gynecol MFM (2020): 100133.
  26. Cohen, J., Vignaux, O., Jacquemard, F. “Covid-19 in pregnant women: General data from a French National Survey.” Eur J Obstet Gynecol Reprod Biol 251 (2020): 267–8.
  27. Conde-Agudelo, A, Romero, R. “SARS-COV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis.” Am J Obstet Gynecol 226.1 (2022): 68–89.e3.
  28. Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID-19) Infection in Pregnancy. Guidance (2020).
  29. Pique-Regi, R., Romero, R., Tarca, A.L., et al. “Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?” Elife 9 (2020): e58716.
  30. Hoffmann, M., Kleine-Weber, H., Schroeder, S., et al. “SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.” Cell 181 (2020): 271– 80.
  31. Lu-Culligan, A., Chavan, A.R., Vijayakumar, P., et al. “Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface.” Med (N. Y.) 2.5 (2021): 591–610.
  32. Royal College of Obstetricians and Gynaecologists. Treatment of COVID-19 in pregnant patients (Dec 2021).
  33. Gurol-Urganci, I., Jardine, J.E., Carroll, F., et al. “Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study.” Am J Obstet Gynecol 225.5 (2021): 522.e1–e11.
  34. Moresi, S., Dell’Aquila, M., Salvi, S., et al. “SARS-CoV-2 Infection in Pregnancy: Clinical Signs, Placental Pathology, and Neonatal Outcome – Implications for Clinical Care.” Front Med 8 (2021): 676870.
  35. Shanes, E.D., Mithal, L.B., Otero, S., et al. “Placental Pathology in COVID-19.” Am J Clin Pathol 154.1 (2020): 23–32.
  36. Di Girolamo, R., Khalil, A., Alameddine, S., et al. “Placental histopathology after SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis.” Am J Obstet Gynecol MFM 3.6 (2021): 100468.
  37. Flores-Pliego, A., Miranda, J., Vega-Torreblanca, S., et al. “Molecular Insights into the Thrombotic and Microvascular Injury in Placental Endothelium of Women with Mild or Severe COVID-19.” Cells 10.2 (2021): 364.
  38. Bernard, I., Limonta, D., Mahal, L.K., Hobman, T.C. “Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19.” Viruses 13.1 (2020): 29.
  39. Chkhaidze, I.Z., Lioznov, D.A., Petrishchev, N.N., Niauri, D.A. “Systemic endotheliitis in terms of novel coronavirus infection COVID-19: gender-related and perinatal risks.” Regional hemodynamics and microcirculation 20.4 (2021): 4–13.
  40. Zaim, S., Chong, J.H., Sankaranarayanan, V., Harky, A. “COVID-19 and Multiorgan Response.” Curr Probl Cardiol 45.8 (2020): 100618. DOI: 10.1016/j.cpcardiol.2020.100618
  41. Kermali, M., Khalsa, R.K., Pillai, K., et al. “The role of biomarkers in diagnosis of COVID-19 – A systematic review.” Life Sci 254 (2020): 117788.
  42. Antypkin, Y.H.Academic lectures on obstetrics and gynecology. Ed. by acad. Y.H. Antypkin. Kyiv. CREATIVE MEDIA LLC (2021): 420 p.
  43. Saw, S.N., Dai, Y., Yap, C.H. “A Review of Biomechanics Analysis of the Umbilical-Placenta System With Regards to Diseases.” Front Physiol 12 (2021): 587635.



How to Cite

Herevych, N., Zhabchenko, I., Kravtsova, Y., Siudmak, O., Kovalenko, T., Bondarenko, O., & Lishchenko, I. (2022). Pregnancy and perinatal outcomes of COVID-19 (SARS-CoV-2): Literature review. REPRODUCTIVE ENDOCRINOLOGY, (65), 53–59.



Pregnancy and childbirth